PubMed Entries
further Publications
Prof. Dr. Guus Rimmelzwaan
Nair, N. (2025). Rift Valley fever virus infection in human PBMC: Characterisation of innate immune response and determining its role in virus dissemination. https://nbn-resolving.org/urn:nbn:de:gbv:95-121976
read more
read more
Nair, N., Wichgers Schreur, P. J., Osterhaus, A. D. M. E., Rimmelzwaan, G. F., & Chitappen Kandiyil, P. (2025). Characterization of innate immune responses induced by Rift Valley fever virus (RVFV) in human PBMCs. In 9th European Congress of Virology 2025: abstracts (PP 224).
read more
read more
Quiñones-Parra, S. M., Gras, S., Nguyen, T. H. O., Farenc, C., Szeto, C., Rowntree, L. C., Chaurasia, P., Sant, S., Boon, A. C. M., Jayasinghe, D., Rimmelzwaan, G. F., Petersen, J., Doherty, P. C., Uldrich, A. P., Littler, D. R., Rossjohn, J., & Kedzierska, K. (2025). Molecular determinants of cross-strain influenza A virus recognition by αβ T cell receptors. Science Immunology, 10(104), Article eadn3805. https://doi.org/10.1126/sciimmunol.adn3805
read more
read more
Agac, A., Meineke, R., Ludlow, M., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2024). RSV infection induces a proinflammatory immune response in primary monocytes. In 17th Graduate School Day: 22/23 November 2024 : abstract book (Zoo T 18). Stiftung Tierärztliche Hochschule Hannover.
read more
read more
Aregay, A., Slunečko, J., Korva, M., Bogovic, P., Resman Rus, K., Knap, N., Beicht, J., Kubinski, M., Saletti, G., Avšič-Županc, T., Steffen, I., Strle, F., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2024). Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins. Npj Vaccines, 9, Article 141. https://doi.org/10.1038/s41541-024-00936-7
read more
read more
Aregay, A., Slunečko, J., Bogovic, P., Korva, M., Resman Rus, K., Knap, N., Beicht, J., Kubinski, M., Saletti, G., Steffen, I., Strle, F., Avšič-Županc, T., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2024). Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity. Emerging Microbes & Infections, 13(1), Article 2317909. https://doi.org/10.1080/22221751.2024.2317909
read more
read more
Aregay, A., Slunečko, J., Bogovic, P., Korva, M., Rus, K. R., Knap, N., Beicht, J., Kubinski, M., Saletti, G., Steffen, I., Sterle, F., Avšič-Županc, T., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2024). Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity. In 8th World One Health Congress: abstract book (1089). https://globalohc.org/8WOHC
read more
read more
Kubinski, M., Beicht, J., Gerlach, T., Aregay, A., Osterhaus, A. D. M. E., Tscherne, A., Sutter, G., Prajeeth, C. K., & Rimmelzwaan, G. F. (2024). Immunity to tick-borne encephalitis virus NS3 protein induced with a recombinant modified vaccinia virus Ankara fails to afford mice protection against TBEV infection. Vaccines, 12(1), Article 105. https://doi.org/10.3390/vaccines12010105
read more
read more
Leroux-Roels, I., Prajeeth, K. C., Aregay, A., Nair, N., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., Kardinahl, S., Pelz, S., Bauer, S., D’Onofrio, V., Alhatemi, A., Jacobs, B., De Boever, F., Porrez, S., Waerlop, G., Punt, C., Hendriks, B., von, van de, et al. (2024). Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against rift valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial. The Lancet: Infectious Diseases, 24(11), 1245–1253. https://doi.org/10.1016/S1473-3099(24)00375-X
read more
read more
Meineke, R., Agac, A., Knittler, M.-C., Ludlow, M., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2024). Respiratory syncytial virus glycoprotein G impedes CX3CR1-activation by CX3CL1 and monocyte function. Npj Viruses, 2, Article 63. https://doi.org/10.1038/s44298-024-00075-9
read more
read more
Prajeeth K. Chittappen, PhD
Nair, N., Chitappen Kandiyil, P., & Rimmelzwaan, G. F. (2024). Innate immune responses induced by attenuated Rift Valley Fever Virus (RVFV) infection in human PBMC. In 17th Graduate School Day: 22/23 November 2024 : abstract book (Zoo T 07). 17th Graduate School Days, 22.11.2024 – 23.11.2024. Stiftung Tierärztliche Hochschule Hannover.
read more
read more
Nair, N., Wichgers Schreur, P. J., Osterhaus, A. D. M. E., Rimmelzwaan, G. F., & Chittappen Kandiyil, P. (2024). Characterisation of innate immune responses induced by the Rift Valley Fever Virus (RVFV) in humans. International One Health Symposium 2024, 17.10.2024 - 19.10.2024.
read more
read more
Nair, N., Wichgers Schreur, P. J., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Chittappen Kandiyil, P. (2024). Innate immune responses induced by Rift Valley Fever Virus (RVFV) infection in human PBMC. Conference title: 23rd Workshop Immunobiology of Viral Infections, 28.10.2024 ‒ 30.10.2024.
read more
read more
Prajeeth, C. K., Zdora, I., Saletti, G., Friese, J., Gerlach, T., Wilken, L., Beicht, J., Kubinski, M., Puff, C., Baumgärtner, W., Kortekaas, J., Wichgers Schreur, P. J., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2024). Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice. Emerging Microbes & Infections, 13, Article 2373313. https://doi.org/10.1080/22221751.2024.2373313
read more
read more
Schweitzer, F., Schröder, L.-J., Gudi, V., Steffen, I., Palus, M., Růžek, D., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Chittappen Kandiyil, P. (2024). From blood to brain: in vitro studies on orthoflavivirus neuroinvasion. In 17th Graduate School Day: 22/23 November 2024 : abstract book (ZSN T 06). Stiftung Tierärztliche Hochschule Hannover.
read more
read more
Beicht, J., Kubinski, M., Zdora, I., Puff, C., Biermann, J., Gerlach, T., Baumgärtner, W., Sutter, G., Osterhaus, A., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice. Frontiers in Immunology, 14, Article 1177324. https://doi.org/10.3389/fimmu.2023.1177324
read more
read more
Kubinski, M., Beicht, J., Zdora, I., Biermann, J., Puff, C., Gerlach, T., Tscherne, A., Baumgärtner, W., Osterhaus, A., Sutter, G., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). A recombinant modified vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection. Frontiers in Immunology, 14, Article 1182963. https://doi.org/10.3389/fimmu.2023.1182963
read more
read more
Kubinski, M., Beicht, J., Zdora, I., Saletti, G., Kircher, M., Petry-Gusmag, M., Steffen, I., Puff, C., Jung, K., Baumgärtner, W., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Prajeeth, C. K. (2023). Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infection. Frontiers in Immunology, 14, Article 1134371. https://doi.org/10.3389/fimmu.2023.1134371
read more
read more
Nair, N., Chittappen Kandiyil, P., & Rimmelzwaan, G. F. (2023). Characterization of innate immune responses induced by the Rift Valley Fever Virus (RVFV) in humans. In 16th Graduate School Day: 24/25 November 2023 : abstract book (Zoo P 14). Stiftung Tierärztliche Hochschule Hannover.
read more
read more
Nair, N., Osterhaus, A., Rimmelzwaan, G., & Prajeeth, C. K. (2023). Rift Valley fever virus: infection, pathogenesis and host immune responses. Pathogens, 12(9), Article 1174. https://doi.org/10.3390/pathogens12091174
read more
read more
Husni Elhabesh, PhD
Elbahesh, H., Gerlach, T., Saletti, G., & Rimmelzwaan, G. F. (2019). Response modifiers: tweaking the immune response against influenza A virus. Frontiers in Immunology, 10: 809. https://doi.org/10.3389/fimmu.2019.00809
read more
read more
Elbahesh, H., Saletti, G., Gerlach, T., & Rimmelzwaan, G. F. (2019). Broadly protective influenza vaccines: design and production platforms. Current Opinion in Virology, 34, 1–9. https://doi.org/10.1016/j.coviro.2018.11.005
read more
read more
Gerlach, T., Elbahesh, H., Saletti, G., & Rimmelzwaan, G. F. (2019). Recombinant influenza A viruses as vaccine vectors. Expert Review of Vaccines, 18(4), 379–392. https://doi.org/10.1080/14760584.2019.1582338
read more
read more
Jansen, J. M., Gerlach, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2019). Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. Journal of Clinical Virology, 119, 44–52. https://doi.org/10.1016/j.jcv.2019.08.009
read more
read more
Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). Influenza virus infections and cellular kinases. Viruses, 11(2: 171). https://doi.org/10.3390/v11020171
read more
read more
Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). In vitro analysis of specific kinases on Influenza A virus infection. In Stiftung Tierärztliche Hochschule Hannover (Ed.), 12th Graduate School Days: 29/30 November 2019 / Stiftung Tierärztliche Hochschule Hannover. Stiftung Tierärztliche Hochschule Hannover.
read more
read more



